The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: irinotecan hcl     Quarter: 2016Q3

Total Records: 86     Number of Pages: 5

DRUGNAME PT EventCount
IRINOTECAN HCL Cholinergic syndrome 1
IRINOTECAN HCL Chromaturia 1
IRINOTECAN HCL Chronic obstructive pulmonary disease 1
IRINOTECAN HCL Colon cancer metastatic 1
IRINOTECAN HCL Cutaneous tuberculosis 1
IRINOTECAN HCL Diarrhoea haemorrhagic 1
IRINOTECAN HCL Diplopia 1
IRINOTECAN HCL Disease progression 1
IRINOTECAN HCL Dysphonia 1
IRINOTECAN HCL Dyspnoea 1
IRINOTECAN HCL Dyspnoea exertional 1
IRINOTECAN HCL Dysuria 1
IRINOTECAN HCL Endometrial disorder 1
IRINOTECAN HCL Failure to anastomose 1
IRINOTECAN HCL Feeding intolerance 1
IRINOTECAN HCL Hepatotoxicity 1
IRINOTECAN HCL Hyperhidrosis 1
IRINOTECAN HCL Hypertensive heart disease 1
IRINOTECAN HCL Hypoaesthesia 1
IRINOTECAN HCL Hypokalaemia 1

Total Records: 86     Number of Pages: 5